Cargando…
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021
Supplemental Digital Content is available in the text.
Autores principales: | Saunders, Jamie, Curto-Garcia, Natalia, Sriskandarajah, Priya, O’Sullivan, Jennifer, Woodley, Claire, Asirvatham, Susan, Campbell-Drew, Marion, Mathias, Jonathan, Ellis, Tim, Baker, Nona, Radia, Deepti H., Ali, Sahra, Kordasti, Shahram, Harrington, Patrick, de Lavallade, Hugues, McLornan, Donal P., Harrison, Claire N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225363/ https://www.ncbi.nlm.nih.gov/pubmed/34179698 http://dx.doi.org/10.1097/HS9.0000000000000609 |
Ejemplares similares
-
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype
por: Harrington, Patrick, et al.
Publicado: (2022) -
Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center
por: Khan, Alesia, et al.
Publicado: (2021) -
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Okikiolu, Jumoke, et al.
Publicado: (2022) -
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
por: Harrington, Patrick, et al.
Publicado: (2022) -
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
por: Harrington, Patrick, et al.
Publicado: (2021)